These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24367248)

  • 1. Utilizing a dynamical description of IspH to aid in the development of novel antimicrobial drugs.
    Blachly PG; de Oliveira CA; Williams SL; McCammon JA
    PLoS Comput Biol; 2013; 9(12):e1003395. PubMed ID: 24367248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broken-Symmetry DFT Computations for the Reaction Pathway of IspH, an Iron-Sulfur Enzyme in Pathogenic Bacteria.
    Blachly PG; Sandala GM; Giammona DA; Bashford D; McCammon JA; Noodleman L
    Inorg Chem; 2015 Jul; 54(13):6439-61. PubMed ID: 26098647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the 4Fe-4S Proteins IspG and IspH: an EPR, ENDOR and HYSCORE Investigation.
    Guerra F; Wang K; Li J; Wang W; Liu YL; Amin S; Oldfield E
    Chem Sci; 2014 Apr; 5(4):1642-1649. PubMed ID: 24999381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylerythritol Phosphate Pathway: Enzymatic Evidence for a Rotation in the LytB/IspH-Catalyzed Reaction.
    Chaignon P; Petit BE; Vincent B; Allouche L; Seemann M
    Chemistry; 2020 Jan; 26(5):1032-1036. PubMed ID: 31756006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Broken-Symmetry Density Functional Theory To Characterize the IspH Oxidized State: Implications for IspH Mechanism and Inhibition.
    Blachly PG; Sandala GM; Giammona DA; Liu T; Bashford D; McCammon JA; Noodleman L
    J Chem Theory Comput; 2014 Sep; 10(9):3871-3884. PubMed ID: 25221444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A closer look at the spectroscopic properties of possible reaction intermediates in wild-type and mutant (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase.
    Xu W; Lees NS; Hall D; Welideniya D; Hoffman BM; Duin EC
    Biochemistry; 2012 Jun; 51(24):4835-49. PubMed ID: 22646150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial (
    Huang S; Xue Y; Ma Y; Zhou C
    Front Bioeng Biotechnol; 2022; 10():1057938. PubMed ID: 36524053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exceptionally high percentage of IPP synthesis by Ginkgo biloba IspH is mainly due to Phe residue in the active site.
    Shin BK; Kim M; Han J
    Phytochemistry; 2017 Apr; 136():9-14. PubMed ID: 28139297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of IspH, a [4Fe-4S]2+ enzyme involved in the biosynthesis of isoprenoids via the methylerythritol phosphate pathway.
    Janthawornpong K; Krasutsky S; Chaignon P; Rohmer M; Poulter CD; Seemann M
    J Am Chem Soc; 2013 Feb; 135(5):1816-22. PubMed ID: 23316732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two unexpected promiscuous activities of the iron-sulfur protein IspH in production of isoprene and isoamylene.
    Ge D; Xue Y; Ma Y
    Microb Cell Fact; 2016 May; 15():79. PubMed ID: 27169371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectroscopic and Computational Investigations of Ligand Binding to IspH: Discovery of Non-diphosphate Inhibitors.
    O'Dowd B; Williams S; Wang H; No JH; Rao G; Wang W; McCammon JA; Cramer SP; Oldfield E
    Chembiochem; 2017 May; 18(10):914-920. PubMed ID: 28253432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting isoprenoid biosynthesis for drug discovery: bench to bedside.
    Oldfield E
    Acc Chem Res; 2010 Sep; 43(9):1216-26. PubMed ID: 20560544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insights into the reductive dehydroxylation pathway for the biosynthesis of isoprenoids promoted by the IspH enzyme.
    Abdel-Azeim S; Jedidi A; Eppinger J; Cavallo L
    Chem Sci; 2015 Oct; 6(10):5643-5651. PubMed ID: 28757951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of IspH, a key enzyme in the methylerythritol phosphate pathway using fluoro-substituted substrate analogues.
    Xiao Y; Chang WC; Liu HW; Liu P
    Org Lett; 2011 Nov; 13(21):5912-5. PubMed ID: 21981393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the reaction mechanism of IspH protein by x-ray structure analysis.
    Gräwert T; Span I; Eisenreich W; Rohdich F; Eppinger J; Bacher A; Groll M
    Proc Natl Acad Sci U S A; 2010 Jan; 107(3):1077-81. PubMed ID: 20080550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioorganometallic mechanism of action, and inhibition, of IspH.
    Wang W; Wang K; Liu YL; No JH; Li J; Nilges MJ; Oldfield E
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4522-7. PubMed ID: 20173096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in silico structural insights into Plasmodium LytB protein and its inhibition.
    Bhuyan R; Nandy SK; Seal A
    J Biomol Struct Dyn; 2015; 33(6):1198-210. PubMed ID: 25011618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridine inhibitor binding to the 4Fe-4S protein A. aeolicus IspH (LytB): a HYSCORE Investigation.
    Wang W; Li J; Wang K; Smirnova TI; Oldfield E
    J Am Chem Soc; 2011 May; 133(17):6525-8. PubMed ID: 21486034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Reductive Dehydroxylation Catalyzed by IspH, a Source of Inspiration for the Development of Novel Anti-Infectives.
    Jobelius H; Bianchino GI; Borel F; Chaignon P; Seemann M
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Acting Immuno-Antibiotics: Computational Investigation on Antibacterial Efficacy of Immune Boosters Against Isoprenoid H Enzyme.
    Jamod H; Mehta K; Sakariya A; Shoukani S; Sanapalli BKR; Yele V
    Assay Drug Dev Technol; 2022 Jul; 20(5):225-236. PubMed ID: 35834649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.